GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Imunon Inc (NAS:IMNN) » Definitions » E10

Imunon (Imunon) E10 : $-95.45 (As of Mar. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Imunon E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Imunon's adjusted earnings per share data for the three months ended in Mar. 2024 was $-0.520. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-95.45 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average E10 Growth Rate was 31.20% per year. During the past 5 years, the average E10 Growth Rate was 32.50% per year. During the past 10 years, the average E10 Growth Rate was 15.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Imunon was 36.90% per year. The lowest was -12.80% per year. And the median was 14.40% per year.

As of today (2024-05-26), Imunon's current stock price is $1.51. Imunon's E10 for the quarter that ended in Mar. 2024 was $-95.45. Imunon's Shiller PE Ratio of today is .


Imunon E10 Historical Data

The historical data trend for Imunon's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Imunon E10 Chart

Imunon Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -501.03 -314.90 -205.47 -126.14 -102.69

Imunon Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -113.37 -115.49 -108.26 -102.69 -95.45

Competitive Comparison of Imunon's E10

For the Biotechnology subindustry, Imunon's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Imunon's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Imunon's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Imunon's Shiller PE Ratio falls into.



Imunon E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Imunon's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.52/131.7762*131.7762
=-0.520

Current CPI (Mar. 2024) = 131.7762.

Imunon Quarterly Data

per share eps CPI Adj_EPS
201406 -79.799 100.560 -104.571
201409 -83.999 100.428 -110.219
201412 -54.599 99.070 -72.624
201503 -73.499 99.621 -97.223
201506 -56.699 100.684 -74.208
201509 -39.900 100.392 -52.374
201512 -50.399 99.792 -66.552
201603 -50.399 100.470 -66.103
201606 -39.450 101.688 -51.123
201609 -48.300 101.861 -62.485
201612 -39.300 101.863 -50.841
201703 -46.350 102.862 -59.379
201706 -11.850 103.349 -15.109
201709 -10.500 104.136 -13.287
201712 -4.064 104.011 -5.149
201803 -3.750 105.290 -4.693
201806 -6.900 106.317 -8.552
201809 -3.900 106.507 -4.825
201812 4.800 105.998 5.967
201903 -1.800 107.251 -2.212
201906 -4.350 108.070 -5.304
201909 -3.750 108.329 -4.562
201912 -1.500 108.420 -1.823
202003 -3.000 108.902 -3.630
202006 -2.700 108.767 -3.271
202009 -3.600 109.815 -4.320
202012 -0.785 109.897 -0.941
202103 -3.310 111.754 -3.903
202106 -0.950 114.631 -1.092
202109 -0.940 115.734 -1.070
202112 -0.710 117.630 -0.795
202203 -1.820 121.301 -1.977
202206 -0.870 125.017 -0.917
202209 -0.870 125.227 -0.916
202212 -1.610 125.222 -1.694
202303 -0.680 127.348 -0.704
202306 -0.610 128.729 -0.624
202309 -0.370 129.860 -0.375
202312 -0.520 129.419 -0.529
202403 -0.520 131.776 -0.520

Add all the adjusted EPS together and divide 10 will get our e10.


Imunon  (NAS:IMNN) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Imunon E10 Related Terms

Thank you for viewing the detailed overview of Imunon's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Imunon (Imunon) Business Description

Traded in Other Exchanges
Address
997 Lenox Drive, Suite 100, Lawrenceville, NJ, USA, 08648
Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases.
Executives
James E Dentzer director C/O AMICUS THERAPEUTICS, INC., 6 CEDAR BROOK DRIVE, CRANBURY NJ 08512
Le Goff Corinne director, officer: President and CEO 200 TECHNOLOGY SQUARE, SUITE 300, CAMBRIDGE MA 02139
Michael H Tardugno officer: Chief Executive Offier 10220-L OLD COLUMBIA ROAD, COLUMBIA MD 21046-2364
Frederick J. Fritz director C/O CELSION CORPORATION, 10220-L OLD COLUMBIA ROAD, COLUMBIA MD 21046
Kardaras Constantine John officer: Chief Accounting Officer C/O CELSION CORPORATION, 997 LENOX DRIVE, SUITE100, LAWRENCEVILLE NJ 08648
Christine A Pellizzari director 10 FINDERNE AVENUE, BRIDGEWATER NJ 08807
Stacy Lindborg director C/O BRAINSTORM CELL THERAPEUTICS, INC., 1325 AVENUE OF AMERICAS, 28TH FLR., NEW YORK NY 10019
Donald P Braun director C/O CELSION CORPORATION, 997 LENOX DRIVE, SUITE 100, LAWRENCEVILLE NJ 08648
Alberto R Martinez director C/O CELSION CORPORATION, 997 LENOX DRIVE, SUITE 100, LAWRENCEVILLE NJ 08648
Jeffrey Wayne Church officer: Chief Financial Officer
Robert W Hooper director C/O CELSION CORPORATION, 10220-L OLD COLUMBIA ROAD, COLUMBIA MD 21046
Andreas Voss director C/O CELSION CORPORATION, 997 LENOX DRIVE, SUITE 100, LAWRENCEVILLE NJ 08648
Egwu, Inc. Fka Egen, Inc. 10 percent owner 601 GENOME WAY, SUITE 3400, HUNTSVILLE AL 35806
Khursheed Anwer officer: Chief Scientific Officer C/O CELSION CORPORATION, 997 LENOX DRVIE, SUITE 100, LAWRENCEVILLE NJ 08648
Gregory L Weaver director 185 BERRY STREET, SUITE 6504, SAN FRANCISCO CA 94107